Mariya V. Litvinova

Mariya V. Litvinova

Auto-generated profile, based on publicly available information

Mariya V. Litvinova

Institute of Experimental Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Reviews on Clinical Pharmacology and Drug Therapy
Verified
Journal Article
Open access
PDF file
MLMariya V. Litvinova
Mariya V. Litvinova
EBEugenii R. Bychkov
Eugenii R. Bychkov
ALAndrei Andrei A. Lebedev
Andrei Andrei A. Lebedev
NANikolay A. Arseniev
Nikolay A. Arseniev
PSPetr D. Shabanov
Petr D. Shabanov
BACKGROUND: The development of effective drug delivery to the central nervous system still remains an important problem in pharmacology despite the rapid development of a large number of new treatment strategies in recent years. Recently interest of the intranasal method as delivery route has greatly increased because this method of administration allows to bypass the blood-brain barrier. There is not a single fundamental study comparing intranasal, central and peripheral methods of administration in order to determine the feasibility of using the intranasal route for delivering substances to the brain by far. AIM: Aim is to study the effect of 6-hydroxydopamine (6-OHDA), a neurotoxin that does not penetrate through the blood-brain barrier by various administrations on the behavior of mice. MATERIALS AND METHODS: The experiments were performed on 40 outbred female mice weighing 2025 g. The mice were divided into groups of 10 which were injected with intraventricular, intranasal, intraperitoneal, and intact 6-OHDA. After 21 days, behavioral responses were observed in the Rotarod test, Verticalization, Open Field, and Pole test. RESULTS: 1. A significant difference was found between animals after intraventricular administration of 6-OHDA and the intact control group when studying the behavior of animals in the open field test. 2. The study of coordination activity in the Rotarod test (rotating rod) showed a similar decrease in the retention time on a rotating drum in animals after intranasal and intraventricular administration of 6-OHDA. 3. Only the descent time increased after intranasal administration of 6-OHDA. 4. A significant increase in the motor activity of mice was revealed after intranasal and intraventricular administration of apomorphine in the verticalization test. CONCLUSIONS: It was concluded that a neurotoxin that does not pass through the blood-brain barrier into the central nervous system penetrates through after intranasal administration.

25 August 2022 in Pharmacy Formulas
Verified
Journal Article
Open access
Alexander TrofimovAlexander Trofimov
Alexander Trofimov
MLMariya V. Litvinova
Mariya V. Litvinova
ASAleksandr Schwarz
Aleksandr Schwarz
VKVera Vladislavovna Kosheverova
Vera Vladislavovna Kosheverova
ALAndrei Andrei A. Lebedev
Andrei Andrei A. Lebedev
ШПШварц Александр Павлович
Шварц Александр Павлович
Biological barriers play a key role in maintaining the integrity and functioning of the body at all levels of its organization. The barrier function at the cellular level is based on the hydrophobic properties of the cytoplasmic membrane, which provide selective permeability for various substances, depending on their chemical properties. At higher levels of organization, from tissue to organism, the barrier function is based on intercellular protein complexes of the plasma membrane, which form paracellular diffusion barriers and separate internal and external fluid media, which is a necessary condition for the development and functioning of each organ. The blood-brain barrier (BBB) ​​plays an important role in maintaining the function of the brain. The review reflects the main stages in the embryonic development of the BBB, as well as presents current data on the morphological and functional features of the organization of the BBB, including molecular mechanisms that mediate the barrier function due to the complex participation of vascular cells of cerebral microvessels, as well as gene expression of enzyme complexes, active and passive substance transport mechanisms through the BBB. The high transport selectivity of the BBB is an urgent problem for the delivery of drugs to the brain. At the same time, it is equally important to improve the principles of pharmacotherapy for the correction of impaired BBB functions in various types of pathology of the nervous and other body systems. This review aims to convey to the developers of modern targeted drugs new information about the molecular genetic mechanisms of the transport of substances through the BBB, as well as to draw the attention of specialists in the field of precision medicine to the problem of violations of the barrier function of cerebral vessels in neurological and other diseases of a modern person.

30 June 2025 in Medical academic journal
Verified
Journal Article
Closed access
PDF file
VGVladanka A. Goltz
Vladanka A. Goltz
ALAndrei Andrei A. Lebedev
Andrei Andrei A. Lebedev
EBEvgenii R. Bychkov
Evgenii R. Bychkov
APAnastasia P. Perova
Anastasia P. Perova
SPSarng Pyurveev
Sarng Pyurveev
ЮЮЮров Андрей Юрьевич
Юров Андрей Юрьевич
BACKGROUND: Sexual dysfunctions are of high social significance, and their steady growth necessitates the search for new pharmacological targets for correction. Mental stress is a trigger of decreased sexual activity. Previously, the effect of predator presentation stress on sexual motivation of male rats was established, which manifested itself in a decrease in exploratory activity toward female rats in estrus. The neuropeptide kisspeptin regulates the hypothalamic-pituitary-gonadal system and is involved in the modulation of sexual behavior. AIM: This works aimed to assess the effect of kisspeptin-10 introduced centrally and peripherally on sexual behavior of rats after restraint stress. METHODS: Male Wistar rats were exposed to restraint stress. To assess sexual behavior, a male rat was placed in a cage with a female rat in estrus. The latency time to approach the female and the number of mounts per female within 3 minutes were recorded. RESULTS: The latency time for approaching female rats in stressed animals increased by 1.3 times (p 0.01) compared to intact controls. After intranasal introduction of kisspeptin-10, the latency time decreased by 1.4 times compared to the control group (p 0.05) and by 1.8 times compared to the stressed group without drug introduction (p 0.001). After a single intraperitoneal introduction of kisspeptin-10, the latency time decreased by 2 times compared to the control group (p 0.01) and by 2.6 times compared to the stressed group without drug introduction (p 0.001). After a course of intranasal introduction of kisspeptin-10, the latency time decreased by 2.4 times compared to the control group (p 0.01) and by 3 times compared to the stressed group without drug introduction (p 0.001). After a course of intraperitoneal introduction of kisspeptin-10, the latency time decreased by 2 times (p 0.05) compared to the control group and by 2.4 times compared to the stressed group without drug introduction (p 0.01). After a single intraperitoneal introduction of kisspeptin-10, the number of mounts per female increased by 3.3 times compared to the control group (p 0.001) and by 3 times compared to the stressed group without drug introduction (p 0.01). After a course of intraperitoneal introduction of kisspeptin-10, the number of mounts per female increased by 3.7 times compared to the control group (p 0.001) and by 3.3 times compared to the stressed group without drug introduction (p 0.01). CONCLUSION: Kisspeptin-10 enhances sexual activity in male rats after restraint stress. Intranasal and intraperitoneal drug introduction triggers a reduced latency time of approaching a female rat. After intraperitoneal introduction, the number of mounts per female increases.

30 December 2025 in Reviews on Clinical Pharmacology and Drug Therapy
Verified
Journal Article
Open access
MLMariya V. Litvinova
Mariya V. Litvinova
MAMakar Antonovich Andreev
Makar Antonovich Andreev
VIViсtor V. Iljin
Viсtor V. Iljin
ALAndrei Andrei A. Lebedev
Andrei Andrei A. Lebedev
EBEugenii R. Bychkov
Eugenii R. Bychkov
ШДШабанов Петр Дмитриевич
Шабанов Петр Дмитриевич
Background: To assess the efficacy of drugs used in the treatment of diseases, it is important to understand the physicochemical properties of a compound, particularly its ability to cross cellular membranes. There are many methods for determining the capacity of substances to penetrate the blood–brain barrier (BBB). The distribution of a compound between the membrane and the extracellular fluid can be expressed by a quantitative characteristic of partitioning (lipophilicity), referred to as logP, which is calculated as the ratio of the compound’s distribution between an organic phase and water. Aim: The work aimed to determine and compare parameters that may serve as predictors of BBB penetration in silico and in vitro and to verify the obtained data in in vivo experiments. Methods: Predictors of BBB penetration were assessed using in silico approaches (the Way2Drug portal and the VEGA ZZ software), in vitro methods based on ultraviolet spectrophotometry to determine experimental logP, and pharmacological analysis of drug effects following intraperitoneal injection using behavioral tests: open field, pole test, elevated plus maze, sexual motivation, and rotarod. Results: Predictor values for BBB penetration were determined for 6-hydroxydopamine (6-OHDA), oxytocin, kisspeptin-10, and haloperidol (including DEEP, MEP, MLP, PSA, HBASS, HBDON, logS, logBB, logP, and others). Partition coefficients were calculated based on optical density measurements (6-OHDA, –1.01; kisspeptin-10, –0.79; oxytocin, –0.816; haloperidol, –0.2). A pharmacological evaluation of BBB penetration based on behavioral effects was performed, and theoretical (in silico) and experimental (ultraviolet spectrophotometry) partition coefficients (logPexp) were compared with in vivo pharmacological findings. The combined analyses demonstrated that only haloperidol possesses physicochemical properties favorable for BBB penetration. Conclusions: The study has found that physicochemical properties obtained in silico and in vitro for predicting BBB penetration of drugs are confirmed by pharmacological analysis based on behavioral effects.